Big Money Sentiment increased to 0.95 in Q4 2018. It has change of 0.07, from 2018Q3’s 0.88. The ratio is positive due to Allscripts Healthcare Solutions, Inc. positioning: 32 sold and 65 reduced. 30 funds took stakes and 62 increased stakes. Investors holded 170.90 million in 2018Q3 but now own 170.44 million shares or 0.27% less.
Element Cap Mngmt Ltd Com accumulated 0% or 11,705 shs. Retirement Of Alabama stated it has 0.01% in Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX). 25,810 were accumulated by Blair William & Il. Moreover, Riverhead Mngmt Limited Co has 0.01% invested in Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX). Cwm Limited Liability Corp invested in 0% or 2,838 shs. South Dakota Investment Council invested in 75,400 shs or 0.02% of the stock. 16,641 were reported by National Bank & Trust Of Montreal Can. Millennium Management Ltd Liability Company reported 410,921 shs. Numerixs Invest Tech invested in 0.03% or 11,100 shs. Jpmorgan Chase & Co invested in 2.09M shs or 0% of the stock. Fmr Ltd Liability Corporation, Massachusetts-based fund reported 179 shs. 486,920 are held by Adirondack Research And Mgmt Inc. Foundry Prtn Ltd Liability Com stated it has 23,178 shs. 37,536 are held by First Tru Advsr L P. Her Majesty The Queen In Right Of The Province Of Alberta As Represented By Alberta Invest Management has invested 0.02% in Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX).

Allscripts Healthcare Solutions, Inc. registered $170,721 net activity with 5 buys and 2 sales since December 12, 2018. Shares for $120,840 were bought by Spruill Yancey L.. On Wednesday, December 12 $250,027 worth of Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) was bought by Black Paul. The insider Poulton Richard J. sold $589,233. $10,006 worth of Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) was bought by Aspinall Mara G. on Friday, December 14. 6,000 shs valued at $72,000 were sold by Farley Brian on Friday, January 18. Shares for $9,798 were bought by Garrison Greg.

Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX)’s quarterly earnings will be revealed on May, 2., as reported by Faxor. Analysts predict 0.00 % diference or $0.11 from the $0.11 EPS from 2018. If the current EPS of $0.11 is accurate, MDRX’s profit could be $18.85M. Wall Street now predicts -31.25 % negative EPS growth despite Allscripts Healthcare Solutions, Inc. previous quarter’s EPS of $0.16. MDRX touched $9.57 during the last trading session after $0.02 change.Currently Allscripts Healthcare Solutions, Inc. is downtrending after 22.79% change in last April 14, 2018. MDRX has also 1.39 million shares volume. MDRX underperformed by 27.16% the S&P500.

Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) Ratings Coverage

Total analysts of 9 have positions in Allscripts Healthcare (NASDAQ:MDRX) as follows: 4 rated it a “Buy”, 1 with “Sell” and 4 with “Hold”. The positive are 44%. Since November 2, 2018 according to StockzIntelligence Inc Allscripts Healthcare has 15 analyst reports. On Friday, November 2 the firm earned “Neutral” rating by Cantor Fitzgerald. On Thursday, February 21 the stock has “Hold” rating by Cantor Fitzgerald. On Friday, February 22 Cowen & Co maintained Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) with “Buy” rating. On Friday, November 2 the rating was maintained by Citigroup with “Buy”. In Wednesday, November 14 report Argus Research downgraded the stock to “Hold” rating. On Tuesday, March 12 the rating was maintained by Canaccord Genuity with “Buy”. On Friday, November 2 the rating was maintained by Robert W. Baird with “Outperform”. On Friday, November 2 JP Morgan downgraded Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) rating. JP Morgan has “Neutral” rating and $12 target. On Monday, February 25 Morgan Stanley maintained Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) rating. Morgan Stanley has “Sell” rating and $9 target. On Friday, January 18 the stock of Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) has “Overweight” rating given by KeyBanc Capital Markets.

Allscripts Healthcare Solutions, Inc. provides information technology and services to healthcare organizations in the United States, Canada, and internationally.The firm is worth $1.64 billion. It offers electronic health records, connectivity, private cloud hosting, outsourcing, analytics, patient engagement, clinical decision support, and population health management solutions.4.63 is the P/E ratio. The company??s Clinical and Financial Solutions segment provides integrated clinical software applications and financial and information solutions, which primarily include EHR-related, and financial and practice management software solutions, as well as related installation, support and maintenance, outsourcing, private cloud hosting, revenue cycle management, training, and electronic claims administration services.

For more Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) news brought out briefly go to: Nasdaq.com, Globenewswire.com, Globenewswire.com, Nasdaq.com or Globenewswire.com. The titles are as follows: “Allscripts (MDRX) Q4 Earnings Lag Estimates, Bookings Up Y/Y – Nasdaq” brought out on February 22, 2019, “Allscripts closes previously announced sale of its interests in Netsmart – GlobeNewswire” on January 02, 2019, “EPSi announces partnership with Ilerasoft Nasdaq:MDRX – GlobeNewswire” with a publish date: September 17, 2018, “Pulse8 joins the Health Plan Alliance Group Purchasing Organization with its ground-breaking Formul8â„¢ solution for managing Pharmacy Costs – Nasdaq” and the last “Allscripts to present at the Citi 2018 Global Healthcare Conference – GlobeNewswire” with publication date: December 04, 2018.